Exact Therapeutics AS (OSL:EXTX) FCF Yield % : -20.79 (As of May. 11, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Exact Therapeutics AS's Trailing 12-Month Free Cash Flow is kr-47.39 Mil, and Market Cap is kr227.77 Mil. Therefore, Exact Therapeutics AS's FCF Yield % for today is -20.79%.

The historical rank and industry rank for Exact Therapeutics AS's FCF Yield % or its related term are showing as below:

OSL:EXTX' s FCF Yield % Range Over the Past 10 Years
Min: -24.01 Med: 0 Max: 0
Current: -20.79

OSL:EXTX's FCF Yield % is ranked worse than
58.8% of 1556 companies
in the Biotechnology industry
Industry Median: -14.17 vs OSL:EXTX: -20.79

Exact Therapeutics AS's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Exact Therapeutics AS FCF Yield % Historical Data

The historical data trend for Exact Therapeutics AS's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS FCF Yield % Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-3.39

-10.87

-9.47

-12.31

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial						-9.49	-8.57	-5.39	-16.67	-9.03

Competitive Comparison of Exact Therapeutics AS's FCF Yield %

For the Biotechnology subindustry, Exact Therapeutics AS's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exact Therapeutics AS's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exact Therapeutics AS's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Exact Therapeutics AS's FCF Yield % falls into.

Exact Therapeutics AS FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Exact Therapeutics AS's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-47.388	/	384.9672
	=	-12.31%

Exact Therapeutics AS's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-17.377	*	2	/	384.9672
	=	-9.03%

Exact Therapeutics AS FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Exact Therapeutics AS FCF Yield % Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines